Original research | 101 (73.2) |
Opinion | 32 (23.2) |
Narrative review | 4 (2.9) |
Systematic review | 1 (0.7) |
Tablet-splitting advantages raised | |
Cost savings | 73 (52.9) |
Dose flexibility/titration | 66 (47.8) |
Ease of swallowing | 46 (33.3) |
Tablet-splitting concerns raised | |
Weight/dose variability | 93 (67.4) |
Difficulty breaking tablets | 38 (27.5) |
Loss of mass | 29 (21.0) |
Sustained-release tablets | 27 (19.6) |
Confusion/non-compliance | 24 (17.4) |
Chemical instability | 19 (13.8) |
Primary authors (first and last)a
| |
Pharmacist | 128 (62.7) |
Unknown | 58 (28.4) |
Specialist physician | 9 (4.4) |
Non-clinician | 6 (2.9) |
Generalist physician | 3 (1.5) |
Nurse | 0 (0.0) |
Location of first author | |
North America | 65 (47.1) |
Western Europe | 27 (19.6) |
Asia | 17 (12.3) |
Eastern Europe | 12 (8.7) |
South America | 7 (5.1) |
Africa | 5 (3.6) |
Australia | 5 (3.6) |